PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Mar-2021 Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery University of Birmingham
29-Mar-2021 LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology Nordic Capital
29-Mar-2021 Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials Amzell BV
29-Mar-2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Augustine Therapeutics
29-Mar-2021 Sputnik V approved in Vietnam The Russian Direct Investment Fund
29-Mar-2021 DUNAD THERAPEUTICS EMERGES TO DEVELOP NEXT-GENERATION SMALL MOLECULE THERAPEUTICS BASED ON FIRST TUNEABLE TARGETED PROTEIN DEGRADATION TECHNOLOGY Dunad Therapeutics
29-Mar-2021 Pangaea Data appoints new CFO and three pharmaceutical experts as advisors Pangaea Data
29-Mar-2021 Cytel opens Solara to general release & launches new Trial Optimization Solution for Biotechs Cytel
26-Mar-2021 Bristol Myers Squibb Announces RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in Patients with Previously Untreated Metastatic or Unresectable Melanoma, Meets Primary Endpoint of Progression-Free Survival Bristol Myers Squibb
26-Mar-2021 Optometry Medical Billing Services-Why Outsourcing Can Be Good? 24/7 Medical Billing Services
26-Mar-2021 3 Important ICD 10 Codes for OB GYN Medical Billing 24/7 Medical Billing Services
25-Mar-2021 Invite from Jim Polarine and Geeta Singh, Co-Chairs to join Pharmaceutical Microbiology West Coast Virtual Conference SMi Group
25-Mar-2021 Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors Enterome
25-Mar-2021 MedVector Launches its Prime-Control Technology to Expand Subject Enrollment Beyond Clinical Trial Sites MedVector
25-Mar-2021 SignalChem Enters a Clinical Trial Collaboration with Merck to Evaluate the Effect of SLC-391 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer SignalChem
25-Mar-2021 Anaveon receives CTA approval to start a Phase I/II study to evaluate the safety, dosing and clinical activity of AVN419 in patients with solid tumors Anaveon
25-Mar-2021 Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support Qlucore
25-Mar-2021 AZD1222 US Phase III primary analysis confirms safety and efficacy AstraZeneca
24-Mar-2021 Myovant Sciences and Pfizer Announce Positive Data From Phase 3 Liberty Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids Pfizer
24-Mar-2021 Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2 Pfizer